L-Carnitine

L-carnitine is not a peptide or a hormone. It is a small compound built from two amino acids, lysine and methionine, and made in the liver and kidneys as well as obtained from food — the name comes from carnis, flesh, because it was first isolated from muscle in 1905. Almost all of the body's supply sits in skeletal muscle and the heart.

Its job is transport, and it is the only molecule that can do it. Fatty acids are burned inside mitochondria, the compartments where cells generate energy, but long-chain fatty acids cannot cross the inner mitochondrial membrane on their own. Carnitine attaches to them, carries them through, and returns for the next one. Without it, long-chain fat simply cannot be used as fuel, whatever else the cell is doing.

That makes it unusually well defined for a compound in this category. Carnitine deficiency is a recognised clinical entity with a known biochemical cause, and the shuttle it operates is textbook metabolism rather than a proposed mechanism. The research question is not whether the transport happens but what determines its rate, and whether supply is ever the step that limits it.

• The carnitine shuttle: Three proteins move fatty acids into the mitochondrion, and the first of them is the main control point of the whole pathway. Studying the carrier is how researchers investigate what governs the rate of fat oxidation.

• Fuel selection: Cells continually choose between burning fat and burning glucose. Because the shuttle is where fat enters the system, carnitine availability is a natural place to examine how that choice is made.

• Muscle and cardiac concentration: Most of the body's carnitine is in tissue with sustained energy demand. Work on muscle and heart metabolism uses it to probe how tissue that relies on fat as fuel manages its supply.

• A defined deficiency state: Genetic and acquired deficiencies produce measurable, well-characterised consequences. Few compounds in metabolic research have a natural experiment of that clarity behind them.

Mitochondria are often described as the cell's power stations, and the description is fair: they are where fuel is finally converted into usable energy. They are enclosed by two membranes, and the inner one is highly selective about what may pass. Glucose products enter easily. Long-chain fatty acids do not.

The solution is a relay. An enzyme on the outer surface attaches the fatty acid to carnitine; a transporter carries that pair across the inner membrane; a second enzyme detaches the fatty acid on the other side and sends the carnitine back out. This is the carnitine shuttle, and it is the only route long-chain fat has into the furnace.

The first enzyme in the relay is also a regulated switch. When the cell is being supplied with carbohydrate, a signalling molecule produced during fat synthesis blocks it — there is no sense importing fat for burning while fat is being made. This is why carnitine research is ultimately about regulation rather than quantity: the gate is controlled, and having more of the carrier does not necessarily open it further.

The biochemistry is settled and has been for decades. That carnitine is required for long-chain fatty acid oxidation, how the shuttle operates, and what happens when it fails are all established facts found in any metabolism textbook, supported by human genetic evidence.

Whether adding carnitine to a system that already has enough changes anything is still debated: muscle concentrations are tightly regulated and difficult to raise, and studies in people without a deficiency have produced mixed results. It is supplied for laboratory research only. Its value in the laboratory is that the pathway is textbook: the shuttle, its three proteins and its regulated first step are known quantities to design around.

LC-120 and Lipo-C + Vitamin B12 are lipotropic solutions that include carnitine alongside methionine, inositol and choline, so the comparison between the single compound and the blends is a direct one.

AOD-9604 and AICAR approach fat metabolism from the signalling end rather than the transport end — one derived from a hormone fragment, the other from an energy-sensing pathway. Carnitine is machinery; those are instructions. Lemon Bottle is a multi-component solution rather than a single compound, which is a third kind of preparation again.